TMC Life Sciences Berhad reported earnings results for the third quarter and nine months ended March 31, 2024. For the third quarter, the company reported sales was MYR 86.07 million compared to MYR 81.58 million a year ago. Net income was MYR 9.96 million compared to MYR 14.29 million a year ago. Basic earnings per share from continuing operations was MYR 0.0057 compared to MYR 0.0082 a year ago. Diluted earnings per share from continuing operations was MYR 0.0057 compared to MYR 0.0082 a year ago.
For the nine months, sales was MYR 272.29 million compared to MYR 226.79 million a year ago. Net income was MYR 39.62 million compared to MYR 26.01 million a year ago. Basic earnings per share from continuing operations was MYR 0.0227 compared to MYR 0.0149 a year ago. Diluted earnings per share from continuing operations was MYR 0.0227 compared to MYR 0.0149 a year ago.